TheProfitWatch

PHIO - Phio Pharmaceuticals Corp. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.08 0.04 (4.17%) 0.0 (0.0%) 0.0 (0.0%) 0.0 (0.0%) 0.11 (10.19%) -0.08 (-7.02%) 0.03 (2.54%) 0.01 (0.85%)

Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.45
Diluted EPS:
-0.45
Basic P/E:
-2.5
Diluted P/E:
-2.5
RSI(14) 1m:
50.0
VWAP:
1.13
RVol:

Events

Period Kind Movement Occurred At

Related News